Showing results (11-20 of 6,841) with videos related to

Sort By:
Pageof 685
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2023
The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United KingdomMikel Berdud, Niklas Wallin-Bernhardsson, Bernarda Zamora, et al.
Cost Effectiveness and Resource Allocation : C/E|October 30, 2022
Estimating health system opportunity costs: the role of non-linearities and inefficiencyKarla Hernandez-Villafuerte, Bernarda Zamora, Yan Feng, et al.
Pharmacoeconomics|February 4, 2024
Incorporating Real Option Value in Valuing Innovation: A Way ForwardMeng Li, Louis P Garrison
Health Affairs (Project Hope)|May 22, 2003
The efficient use of pharmaceuticals: does Europe have any lessons for a Medicare drug benefit?Adrian Towse
Health Economics|June 28, 2007
If it ain't broke, don't price fix it: the OFT and the PPRSAdrian Towse
British Journal of Clinical Pharmacology|August 19, 2010
Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?Adrian Towse
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and RecommendationsLouis P Garrison, Ed Pezalla, Adrian Towse, et al.
The American Journal of Managed Care|December 1, 2015
Private sector risk-sharing agreements in the United States: trends, barriers, and prospectsLouis P Garrison, Josh J Carlson, Preeti S Bajaj, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 7, 2019
How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic MelanomaMeng Li, Anirban Basu, Caroline Bennette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task forceLouis P Garrison, Adrian Towse, Andrew Briggs, et al.
Pageof 685